Psilocybin, the active compound in "magic mushrooms," has shown promise as an effective antidepressant in clinical trials, particularly for individuals with treatment-resistant depression and major... Continue reading
Page 4
Psilocybin, the active ingredient in hallucinogenic mushrooms, has been found effective in treating severe depression for up to 12 weeks in a double-blind, randomized, controlled... Continue reading
This study investigated the impact of a guide's personal experience with psilocybin on the therapeutic outcomes of psilocybin-assisted therapy for depression. The results revealed no... Continue reading
This study investigated the impact of a guide's personal experience with psilocybin on the therapeutic outcomes of psilocybin-assisted therapy for depression. The results revealed no... Continue reading
This systematic review examines the therapeutic potential and safety profile of psilocybin, a naturally occurring psychoactive compound, in treating psychiatric disorders such as treatment-resistant depression,... Continue reading
This paper presents a comprehensive study evaluating the efficacy and safety of psilocybin-assisted therapy in treating major depressive disorder (MDD) over a 12-month follow-up period,... Continue reading
A randomized controlled trial showed that psilocybin treatment rapidly and sustainably reduced anxiety and depression symptoms in patients with life-threatening cancer. Psilocybin led to significant... Continue reading
The paper "The Efficacy of Psilocybin in the Treatment of Depression and Anxiety: A Meta-Analysis" presents a comprehensive review of 12 randomized controlled trials, demonstrating... Continue reading
Showing 31–38 of 38 posts